What PALVELLA THERAPEUTICS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 51 | 76 |
| Total trades | 61 | 108 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 25,730 | 72,293 |
| Disposed | 80,730 | 119,448 |
| Net activity | −55,000 | −47,155 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −200 | $169.78 | −$34K | 0 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −600 | $168.73 | −$101K | 200 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −1,200 | $167.75 | −$201K | 800 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −1,133 | $166.76 | −$189K | 2,000 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −1,467 | $165.78 | −$243K | 3,133 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Open-market sale · S | −1,650 | $164.14 | −$271K | 4,600 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 11 | Exercise / conversion · M | +6,250 | $9.79 | +$61.2K | 6,250 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −800 | $172.12 | −$138K | 0 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −550 | $169.03 | −$93K | 800 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −200 | $167.81 | −$33.6K | 1,350 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −1,500 | $166.91 | −$250K | 1,550 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −1,651 | $165.85 | −$274K | 3,050 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −1,449 | $164.85 | −$239K | 4,701 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Open-market sale · S | −100 | $163.34 | −$16.3K | 6,150 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Exercise / conversion · M | +1,984 | $9.79 | +$19.4K | 6,250 |
| Martini Jeffrey S | Chief Scientific Officer | Nov 10 | Exercise / conversion · M | +4,266 | $7.53 | +$32.1K | 4,266 |
| Goin Kathleen | Chief Operating Officer | Oct 21 | Open-market sale · S | −607 | $126.19 | −$76.6K | 0 |
| Goin Kathleen | Chief Operating Officer | Oct 21 | Open-market sale · S | −1,663 | $125.16 | −$208K | 607 |
| Goin Kathleen | Chief Operating Officer | Oct 21 | Open-market sale · S | −2,043 | $123.62 | −$253K | 2,270 |
| Goin Kathleen | Chief Operating Officer | Oct 21 | Exercise / conversion · M | +2,148 | $9.08 | +$19.5K | 4,313 |
Loading...